Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Integrated DNA Technologies Inc
Integrated DNA Technologies Inc
Activities:
Manufacturing
Research & Development
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
IDT launches rhAmpSeq CRISPR analysis system
Validation of specificity for CRISPR genome editing is important for researchers working toward Investigational New Drug (IND) filings which requires on- and off-target data analysis
Research & Development
IDT host a webinar on increasing target specificity with CRISPR
On 16 August Integrated DNA Technologies will host a webinar titled "Increase on-target specificity of CRISPR genome editing using a novel, high-fidelity Cas9 nuclease”
Research & Development
IDT partners with Illumina for NGS library preparation
Leaders in NGS tools collaborate to deliver robust multiplexing capabilities and streamline target enrichment methods
Distribution
IDT appoints LubioScience as distributors in Switzerland
Researchers in Switzerland no longer need to import IDT products – local expertise facilitates ordering
Research & Development
Integrated DNA Technologies acquires oligonucleotide synthesis company ValueGene
Adds new customers with promise to provide seamless support for genomics research
Distribution
Integrated DNA Technologies expands global sales network
Company now selling directly to customers in South Korea
Finance
Integrated DNA Technologies buys oligonucleotide synthesis business of AITbiotech
Increases firm's capacity to deliver locally manufactured products in Singapore
Subscribe now